Harm and risk reduction - Teams Webinar

The first harm reduction policies, in the UK and the Netherlands, had their origins in the HIV crisis of the 1980s, and were aimed at limiting contamination among injecting drug users. The primary aim of harm reduction policies is to reduce the risks associated with drug use, and to promote consumer responsibility. It pays particular attention to marginalized populations (first referred to in Switzerland as “survival aid”) and promotes self-support associations and peer education. Symbolized by needle exchange programs, opiate substitution treatments, low-risk consumption rooms and heroin prescription programs, this model has influenced numerous innovations such as the analysis of substances from the underground market, controlled alcohol consumption and the promotion of vaping. But where does the RdRD begin and end?

with the participation of :
- Ruth Gozlan, head of health at the French Interministerial Mission for the Fight against Drugs and Addictive Behavior (Mildeca)
- Anne Batisse, pharmacist in charge of the Paris addictovigilance center. Fernand Widal Hospital APHP
- Judith Martin-Fernandez, researcher with the PHARes team, Centre Inserm U 1219, University of Bordeaux, coordinator of the “VITAE Etude pilote d'évaluation de l'impact et de la transférabilité d'un dispositif d'accompagnement en RdRD alcool basé sur le rétablissement en santé mentale” project.
- Benjamin Rolland PU-PH of Addictology, Hospices Civils de Lyon (Université Lyon 1) and Honora Englander (University of Oregon Health & Science)

Seminar moderated by Bertrand Lebeau Leibovici, addictologist

Each presentation will be followed by a time for discussion, with an audience made up of politicians,

law and security professionals.

Free registration required: sonny.perseil@lecnam.net